Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III

Journal of Rheumatology

Volumn 24, Issue 4, 1997, Pages 799-802

  Bellamy, Nicholas ^a,k   Kirwan, John ^b   Boers, Maarten ^c   Brooks, Peter ^d   Strand, Vibeke ^e   Tugwell, Peter ^f   Altman, Roy ^g   Brandt, Kenneth ^h   Dougados, Maxime ⁱ   Lequesne, Michel ^j  

^a Victoria Hospital   (Canada)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d St Vincent's Hospital   (United States)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h INDIANA UNIVERSITY   (United States)

ⁱ Hôpital Cochin ^*  (France)

^j Hopitaux de Paris   (France)

^k LONDON HEALTH SCIENCES CENTRE   (Canada)

more..

Author keywords

Core set; Endpoints; Osteoarthritis; Outcome measures

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; MALE; OSTEOARTHRITIS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL;

CLINICAL TRIALS, PHASE III; HAND; HIP JOINT; HUMANS; KNEE JOINT; OSTEOARTHRITIS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 17744407929     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Guidelines for the Clinical Evaluation of Anti-inflammatory and Anti-rheumatic Drugs (Adults and Children). US Department of Health and Human Services. Public Health Services, Food and Drug Administration. Rockville, MD: April 1988:12-5.
2. Guidelines for the Clinical Investigations of Drugs Used in Rheumatic Diseases. European Drug Guidelines, Series 5, World Health Organization, Regional Office for Europe, Copenhagen, European League Against Rheumatism. March 1985:21-4.
3. Lequesne M, Brandt K, Bellamy N, et al: Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol 1994;(suppl 41)21:65-73.
4. Group for the Respect of Ethics and Excellence in Science (GREES): Osteoarthritis Section. Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis 1996;55:552-7.
5. Bellamy N: Osteoarthritis. In: Musculoskeletal Clinical Metrology. Dordrecht: Kluwer Academic Publishers, 1993:169-76.
6. Cochrane AL: Effectiveness and Efficiency. Random Reflections on Health Services. London: Nuffield Provincial Hospitals Trust, 1972. (reprinted) London: BMJ, 1989.